指南与共识妇科生殖医学

依据2003年鹿特丹标准诊断但不符合更新指南诊断标准的青少年多囊卵巢综合征患者特征

Adolescents diagnosed with polycystic ovary syndrome under the Rotterdam criteria but not meeting the diagnosis under the updated guideline.
指南 / 共识 · Hum Reprod · 2024-01-01

本回顾性研究纳入2004至2022年就诊的315例依据2003年鹿特丹标准诊断的多囊卵巢综合征青少年及健康对照,比较不符合国际循证指南青少年诊断标准者的代谢与激素特征。结果显示,79例(25.1%)高危组虽约90%不超重或肥胖,但血压、甘油三酯及胰岛素抵抗指标较对照更差,且与符合指南诊断标准者相似。

要点

  • 315例鹿特丹标准诊断的青少年中,79例(25.1%)不符合国际循证指南青少年诊断标准,归为高危组。
  • 高危组约90%不超重或肥胖,与对照相似,但血压、甘油三酯及胰岛素抵抗指标较对照更差。
  • 高危组血清LH水平及LH/FSH比值与符合指南诊断标准者相似,代谢及激素特征与后者有重叠。

核心结论

  • 有PCOS特征但不符合国际循证指南青少年诊断标准者,代谢谱较对照不利,且与符合指南诊断标准者共享相当多的代谢与激素特征。

研究设计与样本

  • 回顾性研究,受试者于2004至2022年就诊,纳入依据2003年鹿特丹标准诊断的青少年PCOS患者及健康对照,所有参与者距月经初潮2至8年。

主要发现

  • 315例鹿特丹标准诊断者中,IM/HA/PCO、IM/HA、HA/PCO、IM/PCO表型分别占206例(65.4%)、30例(9.5%)、12例(3.8%)、67例(21.3%)。
  • 依据国际循证指南,79例(25.1%)HA/PCO或IM/PCO表型者未诊断为PCOS,归为高危组。
  • 符合国际循证指南青少年诊断标准者代谢谱最差(全身性或中心性肥胖程度、胰岛素抵抗频率、糖尿病前期或糖尿病及代谢综合征频率),多毛评分高于高危组或对照。
  • 高危组约90%不超重或肥胖,与对照相似,但血压、甘油三酯及胰岛素抵抗指标较对照更差,且这些指标与符合青少年诊断标准者相似。
  • 高危组血清LH水平及LH/FSH比值升高,与符合青少年诊断标准者相似。

临床怎么用

  • 作者认为,与常规鹿特丹标准相比,近期国际循证指南避免在青少年PCOS诊断中使用超声,仍有机会识别处于风险的年轻女孩,与本研究发现一致。
  • 作者提出对该青少年人群的实用方法包括:确立IM或HA(不指示超声),指定为「高危」PCOS状态并定期检查新发或加重的PCOS相关症状或代谢异常,待月经初潮后8年再评估包括超声或抗苗勒管激素。

局限性

  • 无法评估对照的激素或超声参数。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: What are the characteristics of adolescents diagnosed with polycystic ovary syndrome (PCOS) based on the 2003 Rotterdam criteria, but who do not meet the diagnosis according to the international evidence-based guideline? SUMMARY ANSWER: Adolescents who had features of PCOS but did not meet the evidence-based guideline adolescent criteria exhibited unfavorable metabolic profiles compared to controls and shared considerable metabolic and hormonal features with adolescents who did meet the adolescent criteria. WHAT IS KNOWN ALREADY: The international evidence-based PCOS guideline recommended that ultrasound should not be used for the diagnosis of PCOS in girls with a gynecological age of <8 years. Thus far, few studies have evaluated the clinical characteristics of the girls diagnosed with PCOS based on the Rotterdam criteria but who do not meet the diagnosis according to the updated guideline. STUDY DESIGN, SIZE, DURATION: This is a retrospective study, and subjects attended for care from 2004 to 2022. PARTICIPANTS/MATERIALS, SETTING, METHODS: Adolescent girls with PCOS diagnosed according to the 2003 Rotterdam criteria and healthy controls. All participants were between 2 and 8 years since menarche. MAIN RESULTS AND THE ROLE OF CHANCE: Of the 315 girls diagnosed with PCOS according to the Rotterdam criteria, those with irregular menstruation (IM)/hyperandrogenism (HA)/polycystic ovary (PCO), IM/HA, HA/PCO, and IM/PCO phenotypes accounted for 206 (65.4%), 30 (9.5%), 12 (3.8%), and 67 (21.3%) participants, respectively. According to the evidence-based guideline, 79 girls (25.1%) with the HA/PCO or IM/PCO phenotypes were not diagnosed with PCOS, and aligned to the international guideline; they were designated as the 'at-risk' group. As expected, the girls meeting the evidence-based guideline adolescent criteria showed the worst metabolic profiles (degree of generalized or central obesity, frequency of insulin resistance, prediabetes or diabetes, and metabolic syndrome) and higher hirsutism scores than the at-risk group or controls. Approximately 90% of the at-risk group were not overweight or obese, which was similar to the controls. However, they showed worse metabolic profiles, with higher blood pressure, triglyceride, and insulin resistance parameters than controls; furthermore, these profiles were similar to those of the girls meeting the adolescent criteria. The at-risk group showed similarly elevated serum LH levels and LH/FSH ratio with the girls meeting adolescent criteria. LIMITATIONS, REASONS FOR CAUTION: We could not evaluate hormonal or ultrasound parameters in controls. WIDER IMPLICATIONS OF THE FINDINGS: Compared to the conventional Rotterdam criteria, the recent international evidence-based guideline-avoiding ultrasound in PCOS diagnosis in adolescents-still gives the opportunity to identify young girls at risk, aligned to the findings in this study. A practical approach to this adolescent population would involve establishing IM or HA (with ultrasound not indicated) and designating 'at-risk' PCOS status with regular check-ups for newly developed or worsening PCOS-related symptoms or metabolic abnormalities, with subsequent reassessment including ultrasound or anti-Müllerian hormone, once 8 years post-menarche. STUDY FUNDING/COMPETING INTEREST(S): No funding was received in support of this study. The authors have no conflicts of interest to disclose. TRIAL REGISTRATION NUMBER: N/A.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Kim JJ, Hwang KR, Lee D, et al. Adolescents diagnosed with polycystic ovary syndrome under the Rotterdam criteria but not meeting the diagnosis under the updated guideline. Hum Reprod. 2024. PMID: 38514450. doi:10.1093/humrep/deae042

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。